Expression of the FUS domain restores liposarcoma development in CHOP transgenic mice
- PMID: 11896599
- DOI: 10.1038/sj.onc.1205220
Expression of the FUS domain restores liposarcoma development in CHOP transgenic mice
Abstract
Fusion proteins created by chromosomal abnormalities are key components of mesenchymal cancer development. The most common chromosomal translocation in liposarcomas, t(12;16)(q13;p11), creates the FUS-CHOP fusion gene. In the past, we generated FUS-CHOP and CHOP transgenic mice and have shown that while FUS-CHOP transgenic develop liposarcomas, mice expressing CHOP, which lacks the FUS domain, display essentially normal white adipose tissue (WAT) development, suggesting that the FUS domain of FUS-CHOP plays a specific and critical role in the pathogenesis of liposarcoma. To test the significance of FUS and CHOP domain interactions within a living mouse, we generated mice expressing the FUS domain and crossed them with CHOP-transgenic mice to generate double-transgenic FUSxCHOP animals. Here we report that expression of the FUS domain restores liposarcoma development in CHOP-transgenic mice. Our results provide genetic evidence that FUS and CHOP domains function in trans for the mutual restoration of liposarcoma. These results identify a new mechanism of tumor-associated fusion genes and might have impact beyond myxoid liposarcoma.
Similar articles
-
Liposarcoma initiated by FUS/TLS-CHOP: the FUS/TLS domain plays a critical role in the pathogenesis of liposarcoma.Oncogene. 2000 Dec 7;19(52):6015-22. doi: 10.1038/sj.onc.1204018. Oncogene. 2000. PMID: 11146553
-
The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice.Oncogene. 2000 May 11;19(20):2413-22. doi: 10.1038/sj.onc.1203572. Oncogene. 2000. PMID: 10828883
-
Fat-specific FUS-DDIT3-transgenic mice establish PPARgamma inactivation is required to liposarcoma development.Carcinogenesis. 2007 Oct;28(10):2069-73. doi: 10.1093/carcin/bgm107. Epub 2007 Apr 29. Carcinogenesis. 2007. PMID: 17468515
-
Understanding mesenchymal cancer: the liposarcoma-associated FUS-DDIT3 fusion gene as a model.Semin Cancer Biol. 2005 Jun;15(3):206-14. doi: 10.1016/j.semcancer.2005.01.006. Semin Cancer Biol. 2005. PMID: 15826835 Review.
-
[Cytogenetics and molecular biology of liposarcoma].Zhonghua Bing Li Xue Za Zhi. 2003 Apr;32(2):165-7. Zhonghua Bing Li Xue Za Zhi. 2003. PMID: 12956119 Review. Chinese. No abstract available.
Cited by
-
Preclinical Models of Visceral Sarcomas.Biomolecules. 2023 Nov 6;13(11):1624. doi: 10.3390/biom13111624. Biomolecules. 2023. PMID: 38002306 Free PMC article. Review.
-
Modeling sarcomagenesis using multipotent mesenchymal stem cells.Cell Res. 2012 Jan;22(1):62-77. doi: 10.1038/cr.2011.157. Epub 2011 Sep 20. Cell Res. 2012. PMID: 21931359 Free PMC article. Review.
-
FUS-DDIT3 prevents the development of adipocytic precursors in liposarcoma by repressing PPARgamma and C/EBPalpha and activating eIF4E.PLoS One. 2008 Jul 2;3(7):e2569. doi: 10.1371/journal.pone.0002569. PLoS One. 2008. PMID: 18596980 Free PMC article.
-
Axitinib Has Antiangiogenic and Antitumorigenic Activity in Myxoid Liposarcoma.Sarcoma. 2016;2016:3484673. doi: 10.1155/2016/3484673. Epub 2016 Oct 16. Sarcoma. 2016. PMID: 27822137 Free PMC article.
-
The Fusion Oncogene FUS-CHOP Drives Sarcomagenesis of High-Grade Spindle Cell Sarcomas in Mice.Sarcoma. 2019 Jul 25;2019:1340261. doi: 10.1155/2019/1340261. eCollection 2019. Sarcoma. 2019. PMID: 31427882 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous